Difference between revisions of "Plasminogen (TG2)"
m |
m |
||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:Plasminogen.JPG|200px|{{PAGENAME}}]] | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Plasminogen.JPG|200px|{{PAGENAME}}]] | ||
Line 49: | Line 49: | ||
| | | | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] |
Latest revision as of 11:52, 10 March 2015
Plasminogen (TG2) | |
---|---|
Substrate peptide name | Plasminogen |
Synonyms | - |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Extracellular; Secreted |
Swissprot ID | P00747 |
Reactive glutamines | Q322 |
Reactive lysines | K298 |
Substrate sequence | ENFPCKNLDEN
HTTNSQVRWEY |
Structure | 1KI0 |
Surface accessibility | ASAView pdf
ASAView txt |
Disorder prediction | IUPred |
Reference | PMID:7629099 |
Notes | |